Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma-Reference-Cited by-同舟云学术

Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma

Published:1999-04-01 Issue:7 Volume:103 Page:989-997
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Stafforini Diana M.,Numao Toshio,Tsodikov Alexander,Vaitkus Darius,Fukuda Takeshi,Watanabe Naoto,Fueki Naoto,McIntyre Thomas M.,Zimmerman Guy A.,Makino Sohei,Prescott Stephen M.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference56 articles.

1. Asthma

2. New Directions in Asthma Drug Therapy

3. New Insights Into the Understanding of Asthma

4. Childhood asthma and allergic rhinitis: the role of leukotrienes

5. The role of platelet-activating factor in asthma

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Platelet Activating Factor as a Mediator of Inflammatory Diseases and Preterm Delivery;The American Journal of Pathology;2024-06

2. Signal terminator or signal initiator? The inscrutable role of lipoprotein-associated PAF-acetylhydrolase (PAF-AH) in inflammation;Phospholipases in Physiology and Pathology;2023

3. Platelet Activating Factor (PAF): A Mediator of Inflammation;BioFactors;2022-08-27

4. New transcriptome and clinical findings of platelet‐activating factor in chronic spontaneous urticaria: Pathogenic and treatment relevance;BioFactors;2022-08-04

5. Secretory phospholipase A2: a biomarker of inflammation in autoimmune, bacterial and viral diseases;Medical Immunology (Russia);2022-07-13